| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.04B | 1.02B | 979.24M | 1.10B | 1.21B |
| Gross Profit | 243.30M | 243.54M | 233.23M | 257.10M | 248.81M |
| EBITDA | 106.82M | 129.34M | 140.78M | 106.23M | 122.35M |
| Net Income | 30.68M | 39.92M | 51.01M | 66.29M | 54.07M |
Balance Sheet | |||||
| Total Assets | 1.58B | 1.53B | 1.63B | 1.57B | 1.72B |
| Cash, Cash Equivalents and Short-Term Investments | 157.68M | 115.71M | 90.58M | 78.61M | 68.44M |
| Total Debt | 602.28M | 572.36M | 615.00M | 549.90M | 670.64M |
| Total Liabilities | 805.58M | 739.71M | 786.47M | 682.49M | 794.28M |
| Stockholders Equity | 779.32M | 800.14M | 851.63M | 896.41M | 917.79M |
Cash Flow | |||||
| Free Cash Flow | 294.58M | 364.68M | 356.93M | 394.82M | 244.57M |
| Operating Cash Flow | 322.33M | 393.65M | 384.18M | 421.59M | 270.18M |
| Investing Cash Flow | -18.36M | 13.42M | -26.29M | -38.50M | -14.74M |
| Financing Cash Flow | -320.94M | -378.34M | -342.89M | -368.40M | -234.50M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$282.46M | 9.71 | 3.92% | 10.32% | 2.75% | -21.60% | |
70 Outperform | HK$583.07M | 6.62 | 7.43% | 10.87% | -3.14% | -29.66% | |
66 Neutral | HK$16.40B | 11.25 | 42.05% | 2.53% | 35.28% | 41.20% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
60 Neutral | HK$28.79B | 11.25 | 11.65% | 5.36% | 1.76% | 10.34% | |
51 Neutral | HK$18.35B | -43.18 | -4.30% | 5.00% | -1.71% | 53.04% | |
48 Neutral | HK$930.98M | 92.73 | -12.38% | ― | 52.36% | ― |